At-Home Drug of Abuse (DOA) Testing Market by Product (Rapid DOA Test Kits [Test Cups, Test Dip Cards, Test Strips], Breath Analyzers), by Sample (Urine, Saliva, Hair), by Geography (U.S., Canada, U.K., Germany, France, Italy, China, Japan, India, Australia, Brazil, Mexico, South Africa) - Global Market Size, Share, Development, Growth, and Demand Forecast, 2013-2023

At-Home DOA Testing Market Overview

The global at-home DOA testing market generated $483.6 million revenue in 2017 and is predicted to progress at a CAGR of 9.6% during 2018–2023. Growing illicit drugs use amongst teenagers, rising number of initiatives by the government organizations to reduce the drug abuse levels, and increased production of synthetic cannabinoids, bath salts, and other emerging drugs are boosting the demand for at-home DOA testing products in the market.

GLOBAL RAPID DOA TEST KITS MARKET, BY TYPE, $M (2013-2023)

Based on product, the at-home DOA testing market has been categorized into breath analyzers and rapid DOA test kits. Among these, the rapid DOA test kits category held the larger share in this market in 2017. Increase in adoption of various types of rapid DOA test kits and presence of a large number of players manufacturing such kits are the major factors contributing to the market growth of this category.

On the basis of types of DOA test kits, the rapid DOA test kits market has been categorized into test cups, test strips, test dip cards, and other types of test kits. Of these, the fastest growth during the forecast period is expected from the test cups category. Extensive use of test cups for at-home urine drug testing is a key factor driving the market for this product category.

Urine was the most commonly used sample in the global at-home DOA testing market during the historical period. It is also expected to be the fastest-growing category in the market during the forecast period. Urine drug testing products are widely used for analyzing the presence of illicit drugs in the body, as they are cost-effective and easy to use, due to which the market is expected to attain the highest revenue by 2023.

Geographically, the market for at-home DOA testing products in North America observes the largest share in the global at-home DOA testing market throughout the analysis period. The growth of the North American at-home DOA testing market is mainly driven by the increasing availability of illicit drugs, and rising incidence of drug trafficking.

At-Home DOA Testing Market Dynamics

Growth Drivers

Growing use of illicit drugs amongst teenagers, and increased production and trade of illicit drugs worldwide are the major factors driving the growth of at-home DOA testing market. Globally, rise in the production and trafficking of illegal drugs are expected to drive the growth of market. According to the United Nations Office on Drugs and Crime (UNODC), in Afghanistan, opium production increased by 87% to 9,000 metric tons in 2017 compared to 2016. The area under opium poppy cultivation also increased to 328,000 hectares in 2017, a rise of 63% compared with 201,000 hectares in 2016. Therefore, increase in the production of illicit drugs leads to an increased demand for at-home DOA testing products.

It has been observed that teenagers are eager to try and experiment with various illicit substances, such as alcohol and drugs, as they look a way out from the problems through the use of drugs and eventually become addicted to them. This has increased the need for the parents and educational institutions to adopt at-home DOA testing products like strips and dip cards to check the alcohol and drug presence in the teenagers which leads to increase the demand for at-home DOA testing products.

According to the latest statistics provided by Centers for Disease Control and Prevention (CDC), alcohol, marijuana, and tobacco are the most commonly used substances abused by adolescents. Disturbed family life, pressure from schools and friends, and low self-esteem in teenagers also contribute to the increasing use of drugs amongst the teenagers, thereby, driving the demand for at-home DOA testing products by parents and guardians.

Trends

Rising addiction for synthetic cannabinoids, bath salts, and other emerging drugs is the key trend observed in the at-home DOA testing market. Synthetic cannabinoids are man-made mind-altering chemicals that are either sprayed on dried, shredded plant material so that they can be smoked, or sold as liquids to be vaporized and inhaled in e-cigarettes and other devices. The use of these synthetic drugs amongst the teenagers in the U.S. has been increasing.

The players in the at-home DOA testing market are developing products for testing of these drugs. Other than synthetic cannabinoids, teenagers are also consuming bath salts, and other drugs like Kratom and Krokodil. For instance, according to the National Institute on Drug Abuse (NIDA), in August 2018, the Governor of Connecticut issued a statement in response to a large number of overdoses linked to synthetic cannabinoids (K2 or Spice) in the New Haven area of Connecticut.

Moreover, in May 2018, 49 overdose drug cases due to synthetic cannabinoids were reported in Brooklyn. The adoption of new drugs is an important trend observed for the demand of advanced at-home DOA testing products.

At-Home DOA Testing Market - Competitive Landscape

Key players in the at-home DOA testing market are actively participating in the development of new products for the detection of drug abuse levels. For instance, in July 2018, UCP Biosciences Inc. announced that it would showcase its u-Cup product line of point-of-care DOA testing cups at the 70th Annual Scientific Meeting and Clinical Lab Expo. The company also stated that the cups would be made available in different sizes and shapes.

Some of the other key players in the at-home DOA testing industry are Abbott Laboratories, Orient New Life Medical Co. Ltd., Express Diagnostics Int’l Inc., Assure Tech (Hangzhou) Co. Ltd., Psychemedics Corporation, Confirm BioSciences, Phamatech Inc., Home Health (U.K.) Ltd., and Quest Products Inc.